1.Analysis on the Treatment Costs and Protection Levels of Rare Diseases in China Based on Hemophagocytic Lympho-histiocytosis and Still's Disease
Mingyue LI ; Jiaqi LIU ; Peipei CHAI ; Quan WAN
Chinese Health Economics 2025;44(7):51-54
Objective:To explore the differences in the cost structures of Hemophagocytic Lymphohistiocytosis(HLH)and Still's disease,and provide a basis for optimizing the medical insurance and hierarchical diagnosis and treatment policies for rare diseases.Methods:Based on the theories and methods of SHA 2011,the treatment costs and financing models of HLH and Still's disease in 2020 were calculated and analyzed to calculate its financing mode.Results:In 2020,the treatment cost of HLH in China was 436 million yuan,with 98.62%occurring in inpatient services;the treatment cost of Still's disease was 159 million yuan,with 82.32%occurring in inpatient services.In terms of the financing composition,the proportion of household health expenditure in outpatient services for HLH reached to 65.51%;for adult Still's disease,the proportion of household health expenditure in outpatient services was 65.13%;for pediatric Still's disease,the proportion of household health expenditure in outpatient services was as high as 93.15%,and the compensation from social medical insurance was less than 4%.Conclusion:In China,there are problems such as imbalanced cost structures,uneven distribution of diagnosis and treatment resources,heavy family burdens,and differentiation in the attention paid to rare diseases.It is necessary to improve the accounting system,strengthen grassroots diagnosis and treatment,optimize the financing mechanism,increase the attention to"non-star"rare diseases,and promote universal protection.
2.Study on the Anomaly of Active Utilization Behavior of Traditional Chinese Medicine Health Management Services for the Elderly from the Perspective of Behavioral Economics
Chinese Health Economics 2025;44(3):81-84
Objective:Based on the theory of behavioral economics,it analyzed the causes of behavioral biases in the utilization of traditional Chinese medicine health management services for the elderly and proposes strategies for optimizing their active utilization behavior,providing reference for enhancing traditional Chinese medicine health management services.Methods:Qualitative interviews were conducted to collect the elderly's perceptions and utilization behaviors of traditional Chinese medicine health management services.The prospect theory,nudge theory,and assistance theory of behavioral economics were used to analyze the behavioral biases in the elderly's decision-making process of utilization of traditional Chinese medicine health management services and to propose targeted optimization strategies.Results:The elderly's limited rationality was affected by the influence of information and uncertainty,leading to anchoring effects in the initial impression and overconfidence effects in self-health.When making decisions,the elderly were influenced by the herding effect of group conformity,and loss aversion and preference structure also constrained their active utilization of traditional Chinese medicine health management services.The time discounting of traditional Chinese medicine health management outcomes leaded the elderly to have a preference for intertemporal choices.Conclusion:It is needed to build a supportive social environment to adjust the cognitive biases of the elderly;establish standardized social systems to highlight the positive effects of framing;enhance the health literacy of traditional Chinese medicine to facilitate rational decision-making.
3.Estimates and Analysis of Regional Total Health Expenditure in China in 2023
Jing FENG ; Peipei CHAI ; Yan LI
Chinese Health Economics 2025;44(2):7-12
Objective:It aims to analyze regional disparity and evolution trend of health financing level and structure,providing a reference for subsequent adjustment and improvement of regional health financing policy.Methods:Based on the estimates of Total Health Expenditure(THE)by financing source,it examined the levels,structures,and trends of regional health financing.Results:In 2023,THE across regions continued to increase,but there are still significant disparities among regions,with the eastern region significantly higher than the central and western regions.Additionally,the structure of THE varied greatly by region,and the share of Out-of-Pocket payment(OOP)still accounted for a relatively high proportion in some regions.Conclusion:There are significant disparities in health investment across different regions in China,which may exacerbate health inequities.The differences in financing structures among regions are pronounced,and some areas face challenges in achieving the targets set out in the 14th Five-Year Plan regarding the proportion of OOP in THE.There is a need to optimize the health financing system,emphasizing inclusive development to ensure that health financing is adequate,effective,equitable,and sustainable.
4.Results and Analysis of National Health Accounts in 2023 in China
Yan LI ; Peipei CHAI ; Jing FENG ; Feng GUO ; Tiemin ZHAI ; Xiaoguang FU ; Quan WAN
Chinese Health Economics 2025;44(2):1-6
Objectives:Accounting Total Health Expenditure(THE)in 2023,analyzing the changes of health financing in China since 2015,summarizing the main problems and challenges faced by health financing in China at present,and putting forward policy suggestions to improve health financing.Methods:Health expenditure accounting methods by financing source and by health provider were applied,and the change of total health expenditure in China is analyzed through the index analysis of time series.Results:THE in 2023 in China was 9 057.58 billion yuan,an increase of 6.77%over the previous year,accounting for 7.00%of GDP,and per capi-ta health expenditure was 6 425.32 yuan.The proportion of government health expenditure in THE decreased to 26.66%,the propor-tion of social health expenditure increased to 46.01%,and the proportion of household Out-of-Pocket(OOP)rebounded to 27.33%.Conclusions:The total scale of health expenditure in China continues to grow,but the growth rate slows down,and the stability and sustainability of health financing need to be strengthened.It is necessary to speed up the construction of a government investment mechanism based on health priority development,improve the social health insurance system,guide the rational resource allocation,and reduce the burden of medical treatment for residents.
5.Analysis of the Burden Trend and the Influencing Factors of Chronic Obstruction Pulmonary in China
Liance LI ; Peipei CHAI ; Quan WAN
Chinese Health Economics 2025;44(9):62-66
Objective:To analyze the changing trends and influencing factors of the Chronic Obstructive Pulmonary Disease(COPD)burden in China,and provide evidence for adjusting related prevention and control policies.Methods:Utilizing the 2021 Global Burden of Disease(GBD)database,it conducted a comprehensive analysis of COPD prevalence,mortality,and disease burden trends in China through disease burden assessment and Age-Period-Cohort(APC)modeling,alongside projections for future trends.Results:From 1990 to 2021,China's age-standardized COPD disease burden showed a declining trend.APC models revealed significant birth cohort effects on COPD prevalence and mortality.Air pollution and tobacco smoke exposure were identified as primary risk factors for COPD-related deaths and disease burden.Projections indicate that the age-standardized prevalence,mortality,and Disability-Adjusted Life Year(DALY)rates of COPD will continue to decrease over the next five years.Conclusion:While China's COPD disease burden has generally declined,prevention and control remain challenging.Significant population heterogeneity in disease burden necessitates targeted interventions for high-risk groups.Establishing an integrated"prevention-diagnosis-control-treatment-rehabilitation"healthcare system is critical to delivering holistic care for COPD patients.
6.Analysis on the Financing Structural Changes and Influencing Factors of Total Health Expenditure in Inner Mongolia
Jiamei WANG ; Zhiwei QUAN ; Peipei CHAI ; Jing SUN
Chinese Health Economics 2025;44(10):43-46,50
Objective:To analyze the structural changes and influencing factors of Total Health Expenditure(THE)in Inner Mongolia from 2008 to 2023,and provide references for formulating and adjusting relevant health policies in the region.Methods:Structural change degree analysis was used to examine the financing structure of THE,while principal component regression was employed to identify the influencing factors of THE.Results:From 2008 to 2023,THE in Inner Mongolia showed continuous growth,with a significant increase in per capita health expenditure,though there is still room for improvement compared with other regions.Government health expenditure and social health expenditure generally showed positive changes,while individual health expenditure showed negative changes.Per capita disposable income,urbanization rate,and per capita regional GDP were positively correlated with THE,while natural population growth rate and hospital bed utilization rate were negatively correlated with THE.Conclusion:THE in Inner Mongolia continued to grow from 2008 to 2023,but problems such as insufficient government investment and the need to optimize the financing structure existed.Given that economic factors dominate THE growth,it is recommended to achieve reasonable control of THE by improving the efficiency of health resources.
7.Analysis on the Treatment Costs and Protection Levels of Rare Diseases in China Based on Hemophagocytic Lympho-histiocytosis and Still's Disease
Mingyue LI ; Jiaqi LIU ; Peipei CHAI ; Quan WAN
Chinese Health Economics 2025;44(7):51-54
Objective:To explore the differences in the cost structures of Hemophagocytic Lymphohistiocytosis(HLH)and Still's disease,and provide a basis for optimizing the medical insurance and hierarchical diagnosis and treatment policies for rare diseases.Methods:Based on the theories and methods of SHA 2011,the treatment costs and financing models of HLH and Still's disease in 2020 were calculated and analyzed to calculate its financing mode.Results:In 2020,the treatment cost of HLH in China was 436 million yuan,with 98.62%occurring in inpatient services;the treatment cost of Still's disease was 159 million yuan,with 82.32%occurring in inpatient services.In terms of the financing composition,the proportion of household health expenditure in outpatient services for HLH reached to 65.51%;for adult Still's disease,the proportion of household health expenditure in outpatient services was 65.13%;for pediatric Still's disease,the proportion of household health expenditure in outpatient services was as high as 93.15%,and the compensation from social medical insurance was less than 4%.Conclusion:In China,there are problems such as imbalanced cost structures,uneven distribution of diagnosis and treatment resources,heavy family burdens,and differentiation in the attention paid to rare diseases.It is necessary to improve the accounting system,strengthen grassroots diagnosis and treatment,optimize the financing mechanism,increase the attention to"non-star"rare diseases,and promote universal protection.
8.Analysis on the Financing Structural Changes and Influencing Factors of Total Health Expenditure in Inner Mongolia
Jiamei WANG ; Zhiwei QUAN ; Peipei CHAI ; Jing SUN
Chinese Health Economics 2025;44(10):43-46,50
Objective:To analyze the structural changes and influencing factors of Total Health Expenditure(THE)in Inner Mongolia from 2008 to 2023,and provide references for formulating and adjusting relevant health policies in the region.Methods:Structural change degree analysis was used to examine the financing structure of THE,while principal component regression was employed to identify the influencing factors of THE.Results:From 2008 to 2023,THE in Inner Mongolia showed continuous growth,with a significant increase in per capita health expenditure,though there is still room for improvement compared with other regions.Government health expenditure and social health expenditure generally showed positive changes,while individual health expenditure showed negative changes.Per capita disposable income,urbanization rate,and per capita regional GDP were positively correlated with THE,while natural population growth rate and hospital bed utilization rate were negatively correlated with THE.Conclusion:THE in Inner Mongolia continued to grow from 2008 to 2023,but problems such as insufficient government investment and the need to optimize the financing structure existed.Given that economic factors dominate THE growth,it is recommended to achieve reasonable control of THE by improving the efficiency of health resources.
9.Study on the Anomaly of Active Utilization Behavior of Traditional Chinese Medicine Health Management Services for the Elderly from the Perspective of Behavioral Economics
Chinese Health Economics 2025;44(3):81-84
Objective:Based on the theory of behavioral economics,it analyzed the causes of behavioral biases in the utilization of traditional Chinese medicine health management services for the elderly and proposes strategies for optimizing their active utilization behavior,providing reference for enhancing traditional Chinese medicine health management services.Methods:Qualitative interviews were conducted to collect the elderly's perceptions and utilization behaviors of traditional Chinese medicine health management services.The prospect theory,nudge theory,and assistance theory of behavioral economics were used to analyze the behavioral biases in the elderly's decision-making process of utilization of traditional Chinese medicine health management services and to propose targeted optimization strategies.Results:The elderly's limited rationality was affected by the influence of information and uncertainty,leading to anchoring effects in the initial impression and overconfidence effects in self-health.When making decisions,the elderly were influenced by the herding effect of group conformity,and loss aversion and preference structure also constrained their active utilization of traditional Chinese medicine health management services.The time discounting of traditional Chinese medicine health management outcomes leaded the elderly to have a preference for intertemporal choices.Conclusion:It is needed to build a supportive social environment to adjust the cognitive biases of the elderly;establish standardized social systems to highlight the positive effects of framing;enhance the health literacy of traditional Chinese medicine to facilitate rational decision-making.
10.Analysis of the Burden Trend and the Influencing Factors of Chronic Obstruction Pulmonary in China
Liance LI ; Peipei CHAI ; Quan WAN
Chinese Health Economics 2025;44(9):62-66
Objective:To analyze the changing trends and influencing factors of the Chronic Obstructive Pulmonary Disease(COPD)burden in China,and provide evidence for adjusting related prevention and control policies.Methods:Utilizing the 2021 Global Burden of Disease(GBD)database,it conducted a comprehensive analysis of COPD prevalence,mortality,and disease burden trends in China through disease burden assessment and Age-Period-Cohort(APC)modeling,alongside projections for future trends.Results:From 1990 to 2021,China's age-standardized COPD disease burden showed a declining trend.APC models revealed significant birth cohort effects on COPD prevalence and mortality.Air pollution and tobacco smoke exposure were identified as primary risk factors for COPD-related deaths and disease burden.Projections indicate that the age-standardized prevalence,mortality,and Disability-Adjusted Life Year(DALY)rates of COPD will continue to decrease over the next five years.Conclusion:While China's COPD disease burden has generally declined,prevention and control remain challenging.Significant population heterogeneity in disease burden necessitates targeted interventions for high-risk groups.Establishing an integrated"prevention-diagnosis-control-treatment-rehabilitation"healthcare system is critical to delivering holistic care for COPD patients.
Result Analysis
Print
Save
E-mail